Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Himmelfarb

Showing results (21-30 of 370) with videos related to

Pageof 37
Sort By:
Nature Reviews. Nephrology|July 3, 2020
Wearable artificial kidney: problems, progress and prospectsJonathan Himmelfarb, Buddy Ratner
The New England Journal of Medicine|November 5, 2010
HemodialysisJonathan Himmelfarb, T Alp Ikizler
Kidney International|August 28, 2009
Hemodialysis access failure: a call to action--revisitedRaymond M Hakim, Jonathan Himmelfarb
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2006
Trials and trade-offs in haemodialysis vascular access monitoringTalat Alp Ikizler, Jonathan Himmelfarb
Journal of the American Society of Nephrology : JASN|December 18, 2012
The inexorable rise of AKI: can we bend the growth curve?Edward D Siew, Jonathan Himmelfarb
The New England Journal of Medicine|November 12, 2013
New therapies for diabetic kidney diseaseJonathan Himmelfarb, Katherine R Tuttle
Journal of the American Society of Nephrology : JASN|March 31, 2023
Resolved: Targeting a Higher Hemoglobin Is Associated with Greater Risk in Patients with CKD Anemia: ConJonathan Himmelfarb, Lynda Anne Szczech
Kidney International|July 24, 2021
Rescuing kidney patients from early demise: role of anti-cytokine therapiesT Alp Ikizler, Jonathan Himmelfarb
Seminars in Dialysis|October 6, 2004
Antioxidant therapy in uremia: evidence-based medicine?Carrie A Gordon, Jonathan Himmelfarb
Handbook of Experimental Pharmacology|December 19, 2009
Mechanisms of drug-induced nephrotoxicityThomas D Nolin, Jonathan Himmelfarb
Pageof 37

Showing results (21-30 of 370) with videos related to

Sort By:
Pageof 37
Nature Reviews. Nephrology|July 3, 2020
Wearable artificial kidney: problems, progress and prospectsJonathan Himmelfarb, Buddy Ratner
The New England Journal of Medicine|November 5, 2010
HemodialysisJonathan Himmelfarb, T Alp Ikizler
Kidney International|August 28, 2009
Hemodialysis access failure: a call to action--revisitedRaymond M Hakim, Jonathan Himmelfarb
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2006
Trials and trade-offs in haemodialysis vascular access monitoringTalat Alp Ikizler, Jonathan Himmelfarb
Journal of the American Society of Nephrology : JASN|December 18, 2012
The inexorable rise of AKI: can we bend the growth curve?Edward D Siew, Jonathan Himmelfarb
The New England Journal of Medicine|November 12, 2013
New therapies for diabetic kidney diseaseJonathan Himmelfarb, Katherine R Tuttle
Journal of the American Society of Nephrology : JASN|March 31, 2023
Resolved: Targeting a Higher Hemoglobin Is Associated with Greater Risk in Patients with CKD Anemia: ConJonathan Himmelfarb, Lynda Anne Szczech
Kidney International|July 24, 2021
Rescuing kidney patients from early demise: role of anti-cytokine therapiesT Alp Ikizler, Jonathan Himmelfarb
Seminars in Dialysis|October 6, 2004
Antioxidant therapy in uremia: evidence-based medicine?Carrie A Gordon, Jonathan Himmelfarb
Handbook of Experimental Pharmacology|December 19, 2009
Mechanisms of drug-induced nephrotoxicityThomas D Nolin, Jonathan Himmelfarb
Pageof 37